Clinical Trial Update: Pharmacokinetics and Safety of BI 695501 [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety update for BI 695501 in healthy volunteers; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• BI 695501

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2018-10-11